1-4 of 4
Jordi Yagüe
Close
Sort by
Journal Articles

Characterization and Prognostic Impact of Oligoclonal Humoral Response in Patients with Multiple Myeloma After Autologous Stem-Cell Transplantation: Long-Term Results From a Single Institution

Natalia Tovar, Carlos Fernández de Larrea, Juan I. Aróstegui, María Teresa Cibeira, Laura Rosiñol, MD, Montserrat Rovira, Montserrat Elena, Xavier Filella, Jordi Yagüe, Joan Blade, MD
Journal: Blood
Blood (2012) 120 (21): 3948.
https://doi.org/10.1182/blood.V120.21.3948.3948
Published: 2012
Journal Articles

Oligoclonal Bands In Patients with Multiple Myeloma In Complete Remission After Induction Chemotherapy: Strong Association with the Use of Novel Agents

Carlos Fernández de Larrea, Natalia Tovar, María Teresa Cibeira, Juan I. Aróstegui, Laura Rosiñol, Montserrat Elena, Xavier Filella, Jordi Yagüe, Joan Blade
Journal: Blood
Blood (2010) 116 (21): 2945.
https://doi.org/10.1182/blood.V116.21.2945.2945
Published: 2010
Journal Articles

Multiple Myeloma In Complete Remission After Autologous Stem Cell Transplantation: Impact of Bone Marrow Plasma Cell Assessment by Conventional Morphology on Disease Progression

Carlos Fernández de Larrea, Natalia Tovar, María Rozman, Laura Rosiñol, Juan I. Aróstegui, María Teresa Cibeira, Montserrat Rovira, Jordi Yagüe, Joan Blade
Journal: Blood
Blood (2010) 116 (21): 2946.
https://doi.org/10.1182/blood.V116.21.2946.2946
Published: 2010
Journal Articles

Fibronectin Upregulates Gelatinase B (MMP-9) and Induces Coordinated Expression of Gelatinase A (MMP-2) and Its Activator MT1-MMP (MMP-14) by Human T Lymphocyte Cell Lines. A Process Repressed Through RAS/MAP Kinase Signaling Pathways

Jordi Esparza, Carme Vilardell, Javier Calvo, Manel Juan, Jordi Vives, Alvaro Urbano-Márquez, Jordi Yagüe, Maria C. Cid
Journal: Blood
Blood (1999) 94 (8): 2754–2766.
https://doi.org/10.1182/blood.V94.8.2754.420k09_2754_2766
Published: 1999